title: One-hour postload plasma glucose levels are associated with kidney dysfunction.
abstract: OBJECTIVE
  A cutoff of 155 mg/dl for 1-hour postload plasma glucose (1hPG) during the oral glucose tolerance test (OGTT) is able to identify patients who are at high risk for type 2 diabetes and vascular atherosclerosis. We aimed to examine whether individuals with 1hPG ≥155 mg/dl are also at increased risk for chronic kidney disease (CKD).
  
  
  METHODS
  Atherosclerosis risk factors, OGTT, and estimated GFR by Chronic Kidney Disease Epidemiology Collaboration equation were analyzed in 1075 white individuals without diabetes.
  
  
  RESULTS
  The area under the receiver operating characteristic curve for 1hPG was the highest (0.700) compared with the areas under the receiver operating characteristic curve of 0, 30-minute, and 2-hour glucose concentrations. Individuals with 1hPG ≥155 mg/dl had a worse cardiometabolic risk profile, exhibiting significantly higher body mass index, BP, triglycerides, and fasting insulin levels and lower HDL, IGF-1 levels, and insulin sensitivity, than individuals with 1hPG <155 mg/dl. Estimated GFR was significantly lower in individuals with 1hPG ≥155 mg/dl. In a logistic regression model adjusted for age and gender, individuals with 1hPG ≥155 mg/dl showed an increased risk for CKD compared with individuals with 1hPG <155 mg/dl. When the logistic regression analysis was restricted to individuals who had normal glucose tolerance, those with 1hPG ≥155 mg/dl showed a higher risk for CKD compared with individuals with 1hPG <155 mg/dl.
  
  
  CONCLUSIONS
  These data suggest that a cutoff point of 155 mg/dl for the 1hPG during OGTT may be helpful in the identification of individuals who are at increased risk for CKD.
authors.affiliation: Department of Experimental and Clinical Medicine, University Magna-Græcia of Catanzaro, Catanzaro, Italy.
authors.forename: Elena
authors.initials: E
authors.lastname: Succurro
authors.forename: Franco
authors.initials: F
authors.lastname: Arturi
authors.forename: Marina
authors.initials: M
authors.lastname: Lugarà
authors.forename: Alessandro
authors.initials: A
authors.lastname: Grembiale
authors.forename: Teresa Vanessa
authors.initials: TV
authors.lastname: Fiorentino
authors.forename: Vittoria
authors.initials: V
authors.lastname: Caruso
authors.forename: Francesco
authors.initials: F
authors.lastname: Andreozzi
authors.forename: Angela
authors.initials: A
authors.lastname: Sciacqua
authors.forename: Marta Letizia
authors.initials: ML
authors.lastname: Hribal
authors.forename: Francesco
authors.initials: F
authors.lastname: Perticone
authors.forename: Giorgio
authors.initials: G
authors.lastname: Sesti
mesh_terms: D000328:Adult; D001786:Blood Glucose / Q000378:metabolism*; D016009:Chi-Square Distribution; D002908:Chronic Disease; D003430:Cross-Sectional Studies; D005260:Female; D005919:Glomerular Filtration Rate; D005951:Glucose Tolerance Test; D006801:Humans; D007558:Italy; D007668:Kidney / Q000503:physiopathology*; D007674:Kidney Diseases / Q000097:blood / Q000175:diagnosis* / Q000209:etiology / Q000503:physiopathology; D016015:Logistic Models; D008297:Male; D008875:Middle Aged; D011237:Predictive Value of Tests; D012372:ROC Curve; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors
chemical_list: D001786:Blood Glucose